United Arab Emirates Influenza Drug Market to 2032
Overview
The United Arab Emirates Influenza Drug Market is expected to reach a 265.64 USD Million by 2032 and is projected to grow at a CAGR of 6.39% from 2025 to 2032.
Revenue, 2024 (USD Million)
178.08
Forecast, 2032 (USD Million)
265.64
CAGR, 2024 - 2032
6.39%
Report Coverage
United Arab Emirates
United Arab Emirates Influenza Drug Market 2018-2032 USD Million
United Arab Emirates Influenza Drug Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 178.08 USD Million
- Projected Market Size (2032): 265.64 USD Million
- CAGR (2025-2032): 6.39%
Key Findings of United Arab Emirates Influenza Drug Market
- The United Arab Emirates Influenza Drug Market was valued at 178.08 USD Million in 2024.
- The United Arab Emirates Influenza Drug Market is likely to grow at a CAGR of 6.39% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Vaccines in Treatment Segment accounted for the largest share of the market with a revenue of 308.65 USD Million
- The fastest growing segment Oral in Route of Administration Segment grew Fastest with a CAGR of 7.24% during the forecast period from 2024 to 2032.
United Arab Emirates Influenza Drug Market Scope
United Arab Emirates Influenza Drug Market Segmentation & Scope
Treatment
- Drugs
- Vaccines
Route of Administration
- Intravenous
- Intranasal
- Intradermal
- Intramuscular
- Oral
Age
- Pediatrics
- Adults
End User
- Homecare
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Type
- Influenza C
- Influenza B
- Influenza A
United Arab Emirates Influenza Drug Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 178.08 USD Million |
| Market Value in 2032 | 265.64 USD Million |
| CAGR (2025-2032) | 6.39% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Treatment,Route of Administration,Age,End User,Distribution Channel,Type |
Regional Insights:
-
Leading Market (2024-2032): United Arab Emirates, leading in terms of revenue 178.08 USD Million in 2024
- Key Country: United Arab Emirates, leading in terms of revenue with value of 178.08 USD Million in 2024.
Segments and Scope
-
United Arab Emirates Influenza Drug Market to 2032, By Treatment
- Vaccines is the largest segment in United Arab Emirates Influenza Drug Market to 2032 with a revenue of 308.65 USD Million in the year 2024.
- Vaccines is the Fastest growing segment in United Arab Emirates Influenza Drug Market to 2032 with a Growth rate of 6.41 % in forecast period 2025-2032.
-
United Arab Emirates Influenza Drug Market to 2032, By Route of Administration
- Oral is the largest segment in United Arab Emirates Influenza Drug Market to 2032 with a revenue of 74.38 USD Million in the year 2024.
- Oral is the Fastest growing segment in United Arab Emirates Influenza Drug Market to 2032 with a Growth rate of 7.24 % in forecast period 2025-2032.
-
United Arab Emirates Influenza Drug Market to 2032, By Age
- Adults is the largest segment in United Arab Emirates Influenza Drug Market to 2032 with a revenue of 91.13 USD Million in the year 2024.
- Pediatrics is the Fastest growing segment in United Arab Emirates Influenza Drug Market to 2032 with a Growth rate of 5.91 % in forecast period 2025-2032.
-
United Arab Emirates Influenza Drug Market to 2032, By End User
- Hospitals is the largest segment in United Arab Emirates Influenza Drug Market to 2032 with a revenue of 127.62 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in United Arab Emirates Influenza Drug Market to 2032 with a Growth rate of 6.57 % in forecast period 2025-2032.
-
United Arab Emirates Influenza Drug Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in United Arab Emirates Influenza Drug Market to 2032 with a revenue of 97.08 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in United Arab Emirates Influenza Drug Market to 2032 with a Growth rate of 6.74 % in forecast period 2025-2032.
-
United Arab Emirates Influenza Drug Market to 2032, By Type
- Influenza A is the largest segment in United Arab Emirates Influenza Drug Market to 2032 with a revenue of 81.39 USD Million in the year 2024.
- Influenza A is the Fastest growing segment in United Arab Emirates Influenza Drug Market to 2032 with a Growth rate of 6.93 % in forecast period 2025-2032.
United Arab Emirates Influenza Drug Market Company Share Analysis
| Company Name |
|
||
| Sanofi | |||
| AstraZeneca | |||
| GSK plc. | |||
| CSL | |||
| F. Hoffmann-La Roche Ltd. | |||
United Arab Emirates Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Million
United Arab Emirates Influenza Drug Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The United Arab Emirates Influenza Drug Market is segmented based on Segmentation Treatment,Route of Administration,Age,End User,Distribution Channel,Type.
United Arab Emirates Influenza Drug Market was valued at USD 178.08(Revenue in USD Million) in 2022.
United Arab Emirates Influenza Drug Market is projected to grow at a CAGR of 6.39% during the forecast period of 2024 to 2032.
The Vaccines segment is expected to dominate the United Arab Emirates Influenza Drug Market, holding a largest market share of 308.65 USD Million in 2024
United Arab Emirates Influenza Drug Market Scope
United Arab Emirates Influenza Drug Market Segmentation & Scope
Treatment
- Drugs
- Vaccines
Route of Administration
- Intravenous
- Intranasal
- Intradermal
- Intramuscular
- Oral
Age
- Pediatrics
- Adults
End User
- Homecare
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Type
- Influenza C
- Influenza B
- Influenza A
Frequently Asked Questions
The United Arab Emirates Influenza Drug Market is segmented based on Segmentation Treatment,Route of Administration,Age,End User,Distribution Channel,Type.
United Arab Emirates Influenza Drug Market was valued at USD 178.08(Revenue in USD Million) in 2022.
United Arab Emirates Influenza Drug Market is projected to grow at a CAGR of 6.39% during the forecast period of 2024 to 2032.
The estimated market value of the United Arab Emirates Influenza Drug Market for final year is USD 265.64 (USD Million).
United Arab Emirates Influenza Drug Market Company Profiling
Frequently Asked Questions
The United Arab Emirates Influenza Drug Market is segmented based on Segmentation Treatment,Route of Administration,Age,End User,Distribution Channel,Type.
United Arab Emirates Influenza Drug Market was valued at USD 178.08(Revenue in USD Million) in 2022.
United Arab Emirates Influenza Drug Market is projected to grow at a CAGR of 6.39% during the forecast period of 2024 to 2032.
The estimated market value of the United Arab Emirates Influenza Drug Market for final year is USD 265.64 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.